NewsRx

Search our medical news database

Atrial Fibrillation

CryoCath Featured Prominently at 2007 Annual Scientific Sessions of the Heart Rhythm Society

Published in Lab Law Weekly, May 25th, 2007

CryoCath Technologies (TSX:CYT), the global leader in cryotherapy products to treat cardiovascular disease, announced the presentation of 15 oral abstracts and posters, all pertaining to the use of CryoCath's technology to treat heart arrhythmias at the 28th Annual Scientific Sessions of the Heart Rhythm Society, to be held in Denver, Colorado May 9-12, 2007.

In addition to these abstracts, CryoCath and cryoablation will be one of the central themes of a CME-accredited symposium, "Broadening the Range of Atrial Fibrillation Therapies." Topics will include: Improving the Safety of Catheter Ablation for Atrial Fibrillation; Focal Catheter Cryoablation Strategies;...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook